2 results
Approved WMOPending
To estimate the effect of rosiglitazone compared to placebo on ischemia-reperfusion injury as assessed by annexin A5 scintigraphy in the human forearm in subjects with the metabolic syndrome.
Approved WMORecruitment stopped
The main objective is to assess the impact of the P4 approach on established markers of glucose metabolism. Secondary objectives are changes in physical characteristics, questionnaires and the indices for beta cell function, hepatic insulin…